Management & Regulatory

I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, as well as a deep understanding of technological innovation in the industry. Today, we’re diving into the recent European Commission approval of Cabometyx for advanced

Imagine a world where thousands of Americans, including children, face the grim reality of kidney failure within a decade due to rare, debilitating conditions like C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN). These diseases, affecting around

I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, as well as a deep understanding of technological innovation in the industry. Today, we’re diving into the recent FDA approval of Gilead Sciences’ Biktarvy for expanded HIV

Imagine living with a condition where even a small bite of protein-rich food could lead to severe neurological damage, a daily reality for thousands of individuals in the U.S. diagnosed with phenylketonuria (PKU), a rare genetic metabolic disorder. Affecting approximately one in every 13,500 to

Hemophilia, a rare inherited bleeding disorder impacting approximately 800,000 individuals globally, has long posed significant challenges for patients and healthcare providers due to the body's impaired ability to form blood clots. For many, the struggle to manage frequent bleeding episodes with

In a landmark effort to strengthen health security across Southeast Asia, Australia and Thailand have embarked on a transformative partnership that promises to reshape the region’s approach to public health, bringing new hope for resilience. Announced on August 11, this collaboration brings